Daniel Choi

5PUBLICATIONS
31CO-AUTHORS
Haematological tumoursEpigenetics (incl. genome methylation and epigenomics)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 23, 2026
CAR-T Targeting of Mutant Calreticulin Establishes a Potentially Curative Stem Cell-Directed Therapy for Myeloproliferative Neoplasms.

Daniel C Choi, Giovanni Medico, Irina V Lebedeva

|Sep 07, 2024
JAK2V617F impairs lymphoid differentiation in myeloproliferative neoplasms.

Daniel C Choi, Nassima Messali, Narasimha Rao Uda

|May 08, 2024
Mapping genotypes to chromatin accessibility profiles in single cells.

Franco Izzo, Robert M Myers, Saravanan Ganesan

|Dec 20, 2022
Crizotinib Has Preclinical Efficacy in Philadelphia-Negative Myeloproliferative Neoplasms.

Lindsay M Gurska, Rachel Okabe, Alexandra Schurer

|Jul 05, 2022
Hematopoietic fitness of JAK2V617F myeloproliferative neoplasms is linked to clinical outcome.

Ghaith Abu-Zeinah, Silvana Di Giandomenico, Daniel Choi

Pageof 1